Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
NF 449: Purinergic Receptor Antagonist for Platelet Studies
2026-08-03
NF 449 stands out as a highly potent and selective purinergic receptor antagonist, enabling precise dissection of P2X1-mediated platelet activation and aggregation. Its exceptional nanomolar efficacy and specificity offer a transformative edge for researchers in antithrombotic agent development and platelet function assays.
-
Inhibiting CaN/FoxO1/FABP4 Prevents Foam Cell Formation in A
2026-08-03
This study uncovers how SERCA2 dysfunction accelerates atherosclerosis by activating the calcineurin/FoxO1/FABP4 pathway, leading to excessive foam cell formation in macrophages. Targeted inhibition of FABP4, including with small-molecule inhibitors, corrects disturbed lipid metabolism and offers a mechanistically precise approach for atherosclerosis research.
-
Amitriptyline HCl in Neuropharmacology: Protocols & Innovati
2026-08-02
Amitriptyline HCl (3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethylpropan-1-amine hydrochloride) unlocks advanced workflows in neurotransmitter receptor modulation and neurodegenerative disease modeling. This guide integrates lipidomics-driven insights and troubleshooting to elevate the reliability of CNS assays.
-
N-octanoyl-L-Homoserine lactone: Workflows & Cancer Risk Ins
2026-08-01
N-octanoyl-L-Homoserine lactone (C8-HSL) enables precise dissection of bacterial quorum sensing in both infection biology and cancer risk research, translating molecular insight into actionable workflows. This article delivers stepwise protocols, troubleshooting guidance, and highlights a breakthrough link between C8-HSL and lung cancer cell aggressiveness.
-
GST-Mediated Insecticide Resistance in M. usitatus: Insights
2026-07-31
This study reveals that glutathione S-transferase (GST) upregulation in Megalurothrips usitatus drives resistance to lambda-cyhalothrin by enhancing antioxidant defenses. Functional inhibition of GST, notably using diethyl maleate, drastically increases insecticide sensitivity, highlighting a mechanistic link between redox regulation and adaptive resistance with practical implications for pest management and oxidative stress research.
-
Computational Hapten Design Enables Dual Detection of Mushro
2026-07-31
This study introduces a computational chemistry-guided strategy for designing haptens and monoclonal antibodies, resulting in a dual-target fluorescent immunochromatographic assay (DT-FICA) that sensitively and simultaneously detects amatoxins and phallotoxins in mushrooms. The approach addresses a critical gap in rapid toxicology screening, with significant implications for food safety and public health.
-
TMRE Mitochondrial Membrane Potential Assay Kit: Beyond ΔΨm
2026-07-30
Explore the TMRE mitochondrial membrane potential assay kit for advanced mitochondrial function analysis, integrating the latest mechanistic insights on sodium-driven dysfunction and practical assay guidance. Distinct from standard guides, this article delivers actionable interpretation frameworks for translational researchers.
-
N-octanoyl-L-Homoserine Lactone: Translational Implications
2026-07-30
Explore N-octanoyl-L-Homoserine lactone (C8-HSL) as more than a quorum-sensing molecule—this article reveals its dual role in microbial pathogenicity and its emerging impact on lung cancer risk, providing advanced assay guidance for infection biology and translational research.
-
Nebulized Risedronate Sodium Microspheres for Emphysema Ther
2026-07-29
This study pioneers the use of inhaled Risedronate Sodium–chitosan microspheres to induce alveolar macrophage apoptosis as a novel strategy for attenuating pulmonary emphysema. The work demonstrates targeted delivery, deep lung deposition, and reduced macrophage burden, suggesting a promising new direction for FPP synthase inhibitor repurposing in respiratory disease.
-
7-Ethyl-10-hydroxycamptothecin: Advanced Colon Cancer Workfl
2026-07-29
7-Ethyl-10-hydroxycamptothecin (SN-38) stands out as a dual-action tool for advanced colon cancer research, targeting both DNA topoisomerase I and the oncogenic FUBP1 pathway. This guide delivers actionable protocols, troubleshooting, and strategic insights—empowering translational researchers to maximize assay fidelity and unlock new experimental avenues.
-
Dihydroartemisinin Applications: mTOR Pathway, Malaria, and
2026-07-28
Dihydroartemisinin, a potent Artemisia plant extract, is a gold-standard tool for research on cell proliferation, mTOR pathway inhibition, and malaria. This article delivers stepwise protocols, advanced troubleshooting, and novel insights, empowering researchers to optimize experimental workflows with APExBIO's high-purity compound.
-
REV1–DHX36 Interaction Facilitates G-Quadruplex DNA Replicat
2026-07-28
The referenced study uncovers a direct interaction between REV1 and the G4 helicase DHX36, revealing a two-tiered mechanism for tolerating G-quadruplex (G4) DNA structures during replication. These findings clarify how cells maintain replication fidelity and genome stability when challenged by non-canonical DNA, with implications for DNA damage response and therapeutic radiosensitization strategies.
-
EZ Cap™ Human PTEN mRNA: Redefining Tumor Suppressor Restora
2026-07-27
Discover how EZ Cap™ Human PTEN mRNA advances tumor suppressor gene mRNA research with enhanced stability and translational efficiency. This article uniquely dissects molecular mechanisms and experimental design strategies for next-generation cancer and gene therapy research.
-
METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC
2026-07-27
Wang et al. reveal how the METTL16-SENP3-LTF axis confers resistance to ferroptosis and promotes tumorigenesis in hepatocellular carcinoma (HCC). These findings clarify a novel epitranscriptomic mechanism underlying iron metabolism and cell death evasion in HCC, suggesting new therapeutic targets for sensitizing tumors to ferroptotic cell death.
-
Efficient Synthesis of Deuterium-Labeled Degarelix Acetate f
2026-07-26
This study presents a reproducible 13-step synthesis of deuterium-labeled degarelix acetate, enabling its use as a robust internal standard in pharmacokinetics and metabolism research. The methodological advances improve analytical accuracy for clinical development of androgen-related therapeutics.